Sandy, UT, United States of America

Manuel F Balandrin

USPTO Granted Patents = 22 

 

Average Co-Inventor Count = 3.7

ph-index = 10

Forward Citations = 516(Granted Patents)


Location History:

  • Salt Lake City, UT (US) (1996 - 1998)
  • Sandy, UT (US) (1999 - 2020)

Company Filing History:


Years Active: 1996-2025

Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Manuel F Balandrin**

Introduction

Manuel F Balandrin, a distinguished inventor based in Sandy, UT, has made significant strides in the field of pharmaceutical innovations. With an impressive portfolio of 21 patents, his work primarily focuses on therapeutic compounds that target central nervous system (CNS) diseases and disorders, showcasing his commitment to improving human health.

Latest Patents

Among his latest patents, Balandrin has developed compounds advantageous in the treatment of central nervous system diseases and disorders. This series of novel amides demonstrates broad pharmaceutical activity, particularly as anticonvulsants and analgesics. The compounds have shown effectiveness against various conditions such as anxiety, depression, insomnia, migraine headaches, schizophrenia, and neurodegenerative diseases, including Parkinson’s and Alzheimer’s disease. Moreover, they exhibit neuroprotective effects, proving useful in treating strokes and traumatic brain or spinal cord injuries.

Career Highlights

Balandrin's career includes pivotal roles at notable institutions such as NPS Pharmaceuticals, Inc. and The Brigham and Women's Hospital, Inc. His research has consistently advanced the understanding and treatment of complex neurological conditions, earning him recognition in the scientific community. His innovations speak to a deep commitment to finding solutions for debilitating disorders that affect millions.

Collaborations

Throughout his career, Balandrin has collaborated with esteemed colleagues, including Bradford C Van Wagenen and Scott T Moe. These partnerships have fostered a rich environment for innovation, enabling the development of groundbreaking compounds that promise to enhance treatment options for individuals suffering from CNS diseases.

Conclusion

Manuel F Balandrin's contributions to the field of pharmaceuticals and his innovative patented compounds exemplify the vital role of inventors in advancing medical science. His work not only highlights the importance of collaboration in research but also demonstrates a passionate dedication to addressing critical health challenges. As the field continues to evolve, Balandrin remains a prominent figure driving innovation for future breakthroughs in the treatment of CNS disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…